Effect of vaginally administered docosahexaenoic acid (DHA) fatty acids on pregnancy outcome

Completed

• Conditions: Pregnancy and Childbirth; ow birth weight, preterm labour, hypertension in pregnancy, gestational diabetes; Complications of pregnancy, childbirth and the puerperium

• Registration Number: ISRCTN39268609
• Lead Sponsor: Italian Society of Prenatal Diagnosis and Fetal Maternal Medicine (S.I.Di.P.) (Italy)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2009-08-04
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

All women with a viable foetus between 18+0 and 24+0 weeks of gestation

Exclusion Criteria

1. History of placental abruption
2. Bleeding episode in the present pregnancy
3. Women using (or used) prostaglandin inhibitors
4. Multiple pregnancy
5. Allergy to fish
6. Regular intake of fish oil

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Timing of pregnancy<br>2. Newborn weight<br><br>Both endpoints will be measured at the end of the trial. No interim analysis will be performed.

Secondary Outcome Measures

Name	Time	Method
1. Hypertensive disorders<br>2. Diabetes<br><br>Both endpoints will be measured at the end of the trial. No interim analysis will be performed.